About EXUMA Biotech
EXUMA Biotech is a private company based in West Palm Beach, Florida. It has reported $132,950,007 raised in three offerings on Form D since February 2017. Its chief executive is Gregory Frost.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 26, 2026 | Aug 20, 2026 | $70,000,000fully sold | 26 | $2.6M | EquityRule 506(b) | Form D ↗ |
| Dec 19, 2019 | Apr 21, 2020 | $18,950,000fully sold | 12 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Jun 7, 2016 | Feb 23, 2017 | $44,000,007of $93.9M target | 3 | $14.6M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $132,950,007 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on EXUMA Biotech's Form D filed Aug 20, 2026.
Frank McCormick
Director
Richard Yan
Vice President of Finance & Controller
Daniel Flynn
Director
Houston Holmes
Director
Earlier filings also listed Scott Segal (director, last listed Apr 2020) and Jay Short (director, last listed Feb 2017).